Aktien Sensor

Merck KGaA has awarded a grant to Neoclease, a startup focused on Parkinson’s disease research, to support the development of its AI-designed gene-editing platform.

McKesson Corp has seen a boost in investor confidence due to revised price targets from Morgan Stanley and Wells Fargo, driven by the company’s promising earnings growth prospects.

Teva Pharmaceutical Industries has formed a strategic partnership with Fosun Pharma to develop a revolutionary new cancer therapy, marking a bold leap forward in the pharmaceutical industry.

Sandoz Group AG is poised to capitalize on the growing demand for affordable treatment options, with the global biosimilars market expected to reach a valuation of over $72 billion by 2035.

WuXi AppTec’s stock price has declined by 6.32% on the Hong Kong Stock Exchange, despite the company’s recognition for sustainability and corporate governance efforts.

Terumo Corporation has partnered with MedHub-AI to market AI-based FFR technology in Japan, aiming to improve coronary physiology assessment and drive growth in the patient temperature monitoring market.

Sartorius Stedim Biotech embarks on a strategic expansion in France, bolstering its manufacturing and R&D capabilities and solidifying its position as a leader in the biotechnology sector.

Elevance Health Inc.’s stock price has fluctuated over the past few years, with recent stability despite a pending class action lawsuit alleging securities fraud.

Roche Holding AG, a pharmaceutical giant, faces scrutiny over failed trials and fatalities linked to its medications, raising concerns about its ability to navigate the risks of research and development.

IQVIA’s stock price is declining despite high demand for its services, as the company faces challenges from the Swiss healthcare system and increasing competition from innovative companies.